Your browser doesn't support javascript.
loading
Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study.
Zuccarello, M; Brott, T; Derex, L; Kothari, R; Sauerbeck, L; Tew, J; Van Loveren, H; Yeh, H S; Tomsick, T; Pancioli, A; Khoury, J; Broderick, J.
Afiliação
  • Zuccarello M; Department of Neurosurgery, University of Cincinnati Medical Center Ohio 45267-0525, USA.
Stroke ; 30(9): 1833-9, 1999 Sep.
Article em En | MEDLINE | ID: mdl-10471432
ABSTRACT
BACKGROUND AND

PURPOSE:

The safety and the effectiveness of the surgical treatment of spontaneous intracerebral hemorrhage (ICH) remain controversial. To investigate the feasibility of urgent surgical evacuation of ICH, we conducted a small, randomized feasibility study of early surgical treatment versus current nonoperative management in patients with spontaneous supratentorial ICH.

METHODS:

Patients with spontaneous supratentorial ICH who presented to 1 university and 2 community hospitals were randomized to surgical treatment or best medical treatment. Principal eligibility criteria were ICH volume >10 cm(3) on baseline CT scan with a focal neurological deficit, Glasgow Coma Scale score >4 at the time of enrollment, randomization and therapy within 24 hours of symptom onset, surgery within 3 hours of randomization, and no evidence for ruptured aneurysm or arteriovenous malformation. The primary end point was the 3-month Glasgow Outcome Scale (GOS). A good outcome was defined as a 3-month GOS score >3.

RESULTS:

Twenty patients were randomized over 24 months, 9 to surgical intervention and 11 to medical treatment. The median time from onset of symptoms to presentation at the treating hospitals was 3 hours and 17 minutes, the time from randomization to surgery was 1 hour and 20 minutes, and the time from onset of symptoms to surgery was 8 hours and 35 minutes. The likelihood of a good outcome (primary outcome

measure:

GOS score >3) for the surgical treatment group (56%) did not differ significantly from the medical treatment group (36%). There was no significant difference in mortality at 3 months. Analysis of the secondary 3-month outcome measures showed a nonsignificant trend toward a better outcome in the surgical treatment group versus the medical treatment group for the median GOS, Barthel Index, and Rankin Scale and a significant difference in the National Institutes of Health Stroke Scale score (4 versus 14; P=0.04).

CONCLUSIONS:

Very early surgical treatment for acute ICH is difficult to achieve but feasible at academic medical centers and community hospitals. The trend toward less 3-month morbidity with surgical intervention in patients with spontaneous supratentorial ICH warrants further investigation of very early clot removal in larger randomized clinical trials.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cerebelares / Hemorragia Cerebral Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 1999 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cerebelares / Hemorragia Cerebral Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 1999 Tipo de documento: Article